Search results for "Phase 2a"

Scalp-Injected RNA Hair Loss Drug Completes Phase 1b Dosing in Australia

Scalp-Injected RNA Hair Loss Drug Completes Phase 1b Dosing in Australia

OliX announced on August 4 that it has completed patient dosing in the Australian Phase 1b clinical trial for OLX104C (compound name: OLX72021), an...
GC Pharma’s Homegrown mRNA Vaccine Advances to Phase 2 Trials

GC Pharma’s Homegrown mRNA Vaccine Advances to Phase 2 Trials

GC Pharma announced on the 11th that South Korea’s Ministry of Food and Drug Safety has approved its Phase 2 clinical trial application for its...
GC Pharma Partners with France’s Osivax to Develop Next-Generation Combination Flu Vaccine

GC Pharma Partners with France’s Osivax to Develop Next-Generation Combination Flu Vaccine

GC Pharma has entered into a strategic partnership with French biotech firm Osivax to develop and commercialize a...
Stem Cell Pioneer Kim Dong-wook Wins KY Cha Academic Award for Breakthrough Parkinson’s Therapy

Stem Cell Pioneer Kim Dong-wook Wins KY Cha Academic Award for Breakthrough Parkinson’s Therapy

Professor Kim Dong-wook of Yonsei University College of Medicine, a pioneer in human embryonic stem cell-based...
Idience Targeted Cancer Drug Candidate ‘Venadaparib’ Granted FDA Fast Track Designation

Idience Targeted Cancer Drug Candidate ‘Venadaparib’ Granted FDA Fast Track Designation

Idience, a novel anticancer drug developer under the Ildong Pharmaceutical Group, announced on the 18th that its...
Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR

Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR

Rznomics, a biotechnology company specializing in RNA-based gene therapies, announced on March 5 that it has been...